Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report.
Guillaume RobergePhilip Stephen WellsPublished in: Thrombosis journal (2021)
We saw no evidence of bioaccumulation indicating a potential role for low dose apixaban for acute VTE in dialysis patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- venous thromboembolism
- peritoneal dialysis
- low dose
- liver failure
- respiratory failure
- atrial fibrillation
- drug induced
- ejection fraction
- newly diagnosed
- heavy metals
- aortic dissection
- case report
- patient reported outcomes
- hepatitis b virus
- intensive care unit
- risk assessment
- extracorporeal membrane oxygenation